-+ 0.00%
-+ 0.00%
-+ 0.00%

BELITE BIO COMPLETES ROLLING SUBMISSION OF NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR TINLAREBANT FOR THE TREATMENT OF STARGARDT DISEASE TYPE 1

Reuters·06/13/2026 01:30:00

Please log in to view news